tirzepatide news october 18 2025 Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Cardiovascular outcomes of semaglutide and

Guidance for industry and FDA staff: Technical considerations for pen, jet, and related injectors intended for use with drugs and biological products

Knowing how to modify a retatrutide dose intelligently separates experienced researchers from those following rigid scripts

When insulin levels are elevated, such as after a carbohydrate-rich meal, insulin tends to dominate receptor binding

If your initial request is denied, dont give up

The panel provides the Spotlight editors with advice and feedback on the quality and relevance of Spotlights public interest health journalism

Retatrutide (12 mg weekly), TRIUMPH-4, 68 weeks: mean weight loss 28.7%